Abstract
Background
Celsior solution (CS) is a high-sodium, low-potassium, low-viscosity extracellular solution that has been used for liver graft preservation in recent years, although experience with it is still limited. We performed an open-label randomized active-controlled trial comparing CS with the University of Wisconsin solution (UW) for liver transplantation (LT), with a follow-up period of 5 years.
Methods
Adult transplant recipients (n = 102) were prospectively randomized to receive either CS (n = 51) or UW (n = 51). The two groups were comparable with respect to donor and recipient characteristics. The primary outcome measure was the incidence of postreperfusion syndrome (PRS). Secondary outcome measures included primary nonfunction (PNF) or primary dysfunction (PDF), liver retransplantation, and graft and patient survival. Other secondary outcome measures were days in the intensive care unit (ICU) and the rates of acute rejection, chronic rejection, infectious complications, postoperative reoperations, and vascular and biliary complications.
Results
In all, 14 posttransplant variables revealed no significant differences between the groups. There were no cases of PNF or PDF. The incidence of PRS was 5.9% in the CS group and 21.6% in the UW group (P = 0.041). After reperfusion, CS revealed greater control of serum potassium (P = 0.015), magnesium levels (P = 0.005), and plasma glucose (P = 0.042) than UW. Respective patient survivals at 3, 12, and 60 months were 95.7, 87.2, and 82.0% for the CS group and 95.7, 83.3, and 66.6% for the UW group (P = 0.123).
Conclusions
While retaining the same degree of safety and effectiveness as UW for LT, CS may yield postliver graft reperfusion benefits, as shown in this study by a significant reduction in the incidence of PRS and greater metabolic control.
Similar content being viewed by others
References
Benichou J, Halgrimson CG, Weil R et al (1977) Canine and human liver preservation for 6–18 hours by cold infusion. Transplantation 24:407–411
Kalayoglu M, Sollinger HW, Stratta RJ et al (1988) Extended preservation of the liver for clinical transplantation. Lancet 1:617–619
Belzer FO (1989) Clinical organ preservation with UW solution. Transplantation 47:1097–1098
Todo S, Nery J, Yanaga K et al (1989) Extended preservation of human liver grafts with UW solution. JAMA 261:711–714
Cofer JB, Klintmalm GB, Howard TK et al (1990) A comparison of UW with Eurocollins preservation solution in liver transplantation. Transplantation 49:1088–1093
Belzer FO, D’Alessandro AM, Hoffmann RM et al (1992) The use of UW solution in clinical transplantation. A 4-year experience. Ann Surg 215:579–583
Abu-Elmagd K, Fung J, Bueno J et al (2000) Logistics and technique for procurement of intestinal, pancreatic, and hepatic grafts from de same donor. Ann Surg 232:680–687
Menasche P, Pradier F, Grousset C et al (1993) Improved recovery of heart transplants with a specific kit of preservation solutions. J Thorac Cardiovasc Surg 105:353–363
Menasché P, Termignon JL, Pradier F et al (1994) Experimental evaluation of Celsior, a new heart preservation solution. Eur J Cardiothorac Surg 8:207–213
Vega JD, Ochsner JL, Jeevanandam V et al (2001) A multicenter, randomized, controlled trial of Celsior for flush and hypothermic storage of cardiac allografts. Ann Thorac Surg 71:1442–1447
Michel P, Vial R, Rodriguez C et al (2002) A comparative study of the most widely used solutions for cardiac graft preservation during hypothermia. J Heart Lung Transplant 21:1030–1039
Remadi JP, Baron O, Roussel JC et al (2002) Myocardial preservation using Celsior solution in cardiac transplantation: early results and 5-year follow-up of a multicenter prospective study of 70 cardiac transplantations. Ann Thorac Surg 73:1495–1499
De Santo LS, Amarelli C, Romano G et al (2006) High-risk heart grafts: effective preservation with Celsior solution. Heart Vessels 21:89–94
Thabut G, Vinatier I, Brugiere O et al (2001) Influence of preservation solution on early graft failure in clinical lung transplantation. Am J Respir Crit Care Med 164:1204–1208
Baron O, Fabre S, Haloun A et al (2002) Retrospective clinical comparison of Celsior solution to modified blood Wallwork solution in lung transplantation for cystic fibrosis. Prog Transplant 12:176–180
Faenza A, Catena F, Nardo B et al (2001) Kidney preservation with University of Wisconsin and Celsior solution: a prospective multicenter randomized study. Transplantation 72:1274–1277
Cavallari A, Cillo U, Nardo B et al (2003) A multicenter pilot prospective study comparing Celsior and University of Wisconsin preserving solutions for use in liver transplantation. Liver Transpl 9:814–821
Boggi U, Vistoli F, Del Chiaro M et al (2004) Pancreas preservation with University of Wisconsin and Celsior solutions: a single center, prospective randomized study. Transplantation 77:1186–1190
Karam G, Compagnon P, Hourmant M et al (2005) A single solution for multiple organ procurement and preservation. Transpl Int 18:657–663
Aggarwal S, Kang Y, Freeman J et al (1993) Postreperfusion syndrome: hypotension after reperfusion of the transplanted liver. J Crit Care 17:154–160
Aggarwal S, Kang Y, Freeman JA et al (1987) Postreperfusion syndrome: cardiovascular collapse following hepatic reperfusion during liver transplantation. Transplant Proc 19(Suppl 3):54–55
Ploeg RJ, D’Alessandro AM, Knechtle SJ et al (1993) Risk factors for primary dysfunction after liver transplantation—a multivariate analysis. Transplantation 55:807–813
Belzer FO, Southard JH (1988) Principles of solid-organ preservation by cold storage. Transplantation 45:673–676
Pedotti P, Cardillo M, Rigotti P et al (2004) A comparative prospective study of two available solutions for kidney and liver preservation. Transplantation 77:1540–1545
Nardo B, Bertelli R, Montalti R et al (2005) Preliminary results of a clinical randomized study comparing Celsior and HTK solutions in liver preservation for transplantation. Transplant Proc 37:320–322
Prien T, Dietl KH, Zander J et al (1989) Bradyarrhythmia with University of Wisconsin preservation solution. Lancet 1:1319–1320
Ramsay M (2008) The reperfusion syndrome: Have we made any progress? Liver Transpl 14:412–414
Garutti Martinez I, Olmedilla L, Perez-Peña JM et al (1997) Response to clamping of the inferior vena cava as a factor for predicting postreperfusion syndrome during liver transplantation. Anesth Analg 84:254–259
Nanashima A, Pillay P, Crawford M et al (2001) Analysis of postrevascularization syndrome after orthotopic liver transplantation: the experience of an Australian liver transplantation center. J Hepatobiliary Pancreat Surg 8:557–563
Ayanoglu HO, Ulukaya S, Tokat Y (2003) Causes of postreperfusion syndrome in living or cadaveric donor liver transplantations. Transplant Proc 35:1442–1444
Moreno C, Sabaté A, Figueras J et al (2006) Hemodynamic profile and tissular oxygenation in orthotopic liver transplantation: influence of hepatic artery or portal vein revascularization of the graft. Liver Transpl 12:1607–1614
Hilmi I, Horton CN, Planinsic RM et al (2008) The impact of postreperfusion syndrome on short-term patient and liver allograft outcome in patients undergoing orthotopic liver transplantation. Liver Transpl 14:504–508
Nakasuji M, Bookallil MJ (2000) Pathophysiological mechanisms of postrevascularization hyperkalemia in orthotopic liver transplantation. Anesth Analg 91:1351–1355
Xia VW, Ghobrial RM, Du B et al (2007) Predictors of hyperkalemia in the prereperfusion, early postreperfusion, and late postreperfusion periods during adult liver transplantation. Anesth Analg 105:780–785
Scott VL, De Wolf AM, Kang Y et al (1996) Ionized hypomagnesemia in patients undergoing orthotopic liver transplantation: a complication of citrate intoxication. Liver Transpl Surg 2:343–347
Lopez-Andujar R, Deusa S, Montalvá E et al (2009) Comparative prospective study of two liver graft preservation solutions: University of Wisconsin and Celsior. Liver Transpl 15:1709–1717
Koneru B, Sterling MJ, Bahramipour PF (2006) Bile duct strictures after liver transplantation: a changing landscape of the Achilles’ heel. Liver Transpl 12:702–704
Moench C, Moench K, Lohse AW et al (2003) Prevention of ischemic-type biliary lesions by arterial back-table pressure perfusion. Liver Transpl 9:285–289
Eghtesad B, Aucejo F, Fung JJ (2006) Preservation solutions in liver transplantation: what are the options? Liver Transp 12:196–198
Puhl G, Olschewski P, Schöning W et al (2006) Low viscosity Histidine-Tryptophan-Ketoglutarate graft flush improves subsequent extended cold storage in University of Wisconsin solution in an extracorporeal rat liver perfusion and rat liver transplantation model. Liver Transpl 12:1841–1849
Lama C, Rafecas A, Figueras J et al (2002) Comparative study of Celsior and Belzer solutions for hepatic graft preservation: preliminary results. Transplant Proc 34:54–55
Adam R, McMaster P, O’Grady JG et al (2003) Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. Liver Transpl 9:1231–1243
Pfitzmann R, Benscheidt B, Langrehr JM et al (2007) Trends and experiences in liver retransplantation over 15 years. Liver Transpl 13:248–257
Yamauchi Y, Wettergren A, Yamashita Y et al (2007) Retransplantation of the liver in adults: long-term outcome and prognostic modeling. Hepatogastroenterology 54:1181–1186
Gustafsson BI, Backman L, Friman S et al (2006) Retransplantation of the liver. Transplant Proc 38:1438–1439
Jain A, Reyes J, Kashyap R et al (2000) Long-term survival after liver transplantation in 4000 consecutive patients at a single center. Ann Surg 232:490–500
Busuttil RW, Farmer DG, Yersiz H et al (2005) Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience. Ann Surg 241:905–916
Acknowledgments
This work was supported by the Gobierno de Aragón (grants B40 and PI036/09) and by F.I.S. from Instituto de Salud Carlos III (grant RD06/0013/1017).
Conflict of interest
The authors declare no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
García-Gil, F.A., Serrano, M.T., Fuentes-Broto, L. et al. Celsior Versus University of Wisconsin Preserving Solutions for Liver Transplantation: Postreperfusion Syndrome and Outcome of a 5-Year Prospective Randomized Controlled Study. World J Surg 35, 1598–1607 (2011). https://doi.org/10.1007/s00268-011-1078-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-011-1078-7